Sarah Houben

Sarah Houben is a Clinical Researcher in Emerging Infectious Diseases at the Institute of Tropical Medicine Antwerp, affiliated with the University of Antwerp. Her work focuses on mpox outbreak epidemiology, vaccine immunogenicity, and neurodegenerative disease pathology.

Research interests span

• Clinical and epidemiological aspects of emerging viral diseases
• Tau protein propagation in Alzheimer's models
• Public health interventions for infectious disease control
• Vaccine dose optimization in vulnerable populations

Key projects include the ALERRT (African CoaLition for Epidemic Research, Response and Training) initiative funded by the European & Developing Countries Clinical Trials Partnership, analyzing mpox outbreaks in the Democratic Republic of the Congo and Burundi.

Her publications highlight collaborations across global health institutions, with a focus on genomic surveillance platforms like MOOD and the interplay between amyloid and tau pathologies in neurodegenerative disease.

• Email: shouben@itg.be